Exposure to prescribed medication in early life and impacts on gut microbiota and disease development
Open Access
- 23 January 2024
- journal article
- review article
- Published by Elsevier in eClinicalMedicine
- Vol. 68, 102428
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81970477, 82070545, 82270574)
This publication has 101 references indexed in Scilit:
- The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probioticNature Reviews Gastroenterology & Hepatology, 2014
- Life at the beginning: perturbation of the microbiota by antibiotics in early life and its role in health and diseaseNature Immunology, 2014
- Histamine‐2 Receptor Blockers Alter the Fecal Microbiota in Premature InfantsJournal of Pediatric Gastroenterology and Nutrition, 2013
- Antibiotic Exposure and IBD Development Among Children: A Population-Based Cohort StudyPediatrics, 2012
- Trends of Outpatient Prescription Drug Utilization in US Children, 2002–2010Pediatrics, 2012
- Early life antibiotic‐driven changes in microbiota enhance susceptibility to allergic asthmaEMBO Reports, 2012
- First evidence of a possible association between gastric acid suppression during pregnancy and childhood asthma: a population‐based register studyClinical & Experimental Allergy, 2009
- The effect of a fructo-oligosaccharide supplemented formula on gut flora of preterm infantsEarly Human Development, 2007
- Ranitidine and late-onset sepsis in the neonatal intensive care unitJournal of Perinatal Medicine, 2007
- Risk Factors for Nosocomial Infections in Selected Neonatal Intensive Care Units in Colombia, South AmericaJournal of Perinatology, 2005